Literature DB >> 21176977

Hypertension and angiogenesis in the aging kidney: a review.

Delfim Duarte1, Carla Santos-Araújo, Adelino F Leite-Moreira.   

Abstract

With advanced aging, main components of the kidney are altered, including blood vessels, glomeruli and tubulointerstitium. Disruption in these 3 elements is interconnected and associated with several modifications, such as loss of kidney mass and systemic, metabolic and immunologic diseases. In this review we focus on renal blood vessels, the key role of hypertension and angiogenesis in the elderly kidney, the hemodynamic and molecular mechanisms underlying this aging process and the main factors involved. So far, the present data suggests a strong association between renal disease and hypertension and the impairment of regulatory mechanisms, such as angiogenesis in the aging kidney. The endothelium is a key player in vascular control and appears to be also disrupted in many compensatory functions (i.e., vasodilation). Perspectives for the management of the dysfunctional aging kidney are also addressed.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21176977     DOI: 10.1016/j.archger.2010.11.032

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr        ISSN: 0167-4943            Impact factor:   3.250


  8 in total

1.  Adrenomedullin has a role in angiogenic effects of resveratrol in adipose tissues of obese female rats.

Authors:  Ayse Asiye Culum; Muhittin Yurekli
Journal:  Mol Biol Rep       Date:  2020-01-13       Impact factor: 2.316

2.  Heart Failure with Preserved Ejection Fraction: Persistent Diagnosis, Therapeutic Enigma.

Authors:  Taslima Bhuiyan; Mathew S Maurer
Journal:  Curr Cardiovasc Risk Rep       Date:  2011-10

3.  Treadmill Exercise Training Ameliorates Functional and Structural Age-Associated Kidney Changes in Male Albino Rats.

Authors:  Heba R Salem; Manar A Faried
Journal:  ScientificWorldJournal       Date:  2021-11-30

4.  Resveratrol, an Nrf2 activator, ameliorates aging-related progressive renal injury.

Authors:  Eun Nim Kim; Ji Hee Lim; Min Young Kim; Tae Hyun Ban; In-Ae Jang; Hye Eun Yoon; Cheol Whee Park; Yoon Sik Chang; Bum Soon Choi
Journal:  Aging (Albany NY)       Date:  2018-01-11       Impact factor: 5.682

5.  Hypertension and the development of new onset chronic kidney disease over a 10 year period: a retrospective cohort study in a primary care setting in Malaysia.

Authors:  Yook Chin Chia; Siew Mooi Ching
Journal:  BMC Nephrol       Date:  2012-12-24       Impact factor: 2.388

6.  Age-related histological changes in kidneys of Brown Norway rat.

Authors:  Akira Yabuki; Shinichiro Yoneshige; Shin Tanaka; Masashi Tsujio; Sawane Mitani; Osamu Yamato
Journal:  J Vet Med Sci       Date:  2013-10-09       Impact factor: 1.267

Review 7.  Cellular senescence, senescence-associated secretory phenotype, and chronic kidney disease.

Authors:  Wen-Juan Wang; Guang-Yan Cai; Xiang-Mei Chen
Journal:  Oncotarget       Date:  2017-04-21

8.  PPARα Agonist, MHY3200, Alleviates Renal Inflammation during Aging via Regulating ROS/Akt/FoxO1 Signaling.

Authors:  Min Jo Kim; Dae Hyun Kim; EunJin Bang; Sang Gyun Noh; Pusoon Chun; Takako Yokozawa; Hyung Ryong Moon; Hae Young Chung
Journal:  Molecules       Date:  2021-05-26       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.